Mark Denison

Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers. Read More

Join Hassane Mchaourab, the Louise B. McGavock Professor and professor of molecular physiology and biophysics, as he explores biomedical ethics with leading experts in law, biomedical research and basic sciences on Thursday, Sept. 29, from 11 a.m. to noon. Read More

Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.   Read More

Chancellor Daniel Diermeier presented prestigious awards to seven academic leaders at the Spring Faculty Assembly on April 1. He also announced the establishment of the Chancellor's Award for University Service. Read More

Vanderbilt’s role in shaping each step of the medical response to the COVID-19 pandemic began three decades ago and is grounded in the determination of a small group of scientists to understand coronaviruses. The research, and the faculty and alumni who helped lead it, was the topic of the March 23 Chancellor’s Lecture Series virtual event, “Vanderbilt in the Vanguard: The Decades-Long Journey to a Coronavirus Vaccine.” Read More

Vanderbilt scientists on the front lines of COVID-19 research will share their insights on the pandemic and subsequent vaccine development during a Chancellor’s Lecture Series event on Tuesday, March 23, at 5 p.m. CT, hosted by Chancellor Daniel Diermeier. Read More

Vanderbilt first-year students recently met with Buddy Creech, director of the Vanderbilt Vaccine Research Program and associate professor of pediatrics, for a special virtual chat to answer some of their COVID-19 vaccine questions. Read More

Moderna, remdesivir, AstraZeneca. VUMC’s experts have played an integral role in the development of these marquee COVID-19 therapeutics behind the scenes.  Read More

One of the world’s foremost experts on coronaviruses, Dr. Mark R. Denison, shared his research and insights into COVID-19 during a webinar on Dec. 14. A video of the webinar is now available for viewing. Read More

Chancellor Daniel Diermeier will host a special presentation with coronavirus expert Dr. Mark R. Denison on Monday, Dec. 14, from 11 a.m. to noon Central time. Denison’s presentation, “Preparing for the COVID-19 Pandemic ... for 36 Years,” will explore why COVID-19 emerged, his lab’s discoveries, and where we go from here. Read More

Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19. Read More

An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial. Read More

This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus. Read More

From the front lines of patient care to collaborating with scientists across the globe searching for treatments and vaccines, Vanderbilt University Medical Center and Vanderbilt University researchers have been working for months to combat the COVID-19 pandemic. Read More

Researchers at Vanderbilt University Medical Center are playing a key role in the development of a potential new antiviral drug to treat COVID-19. Read More

Nine Vanderbilt faculty members who have been awarded endowed chairs were recently honored by Interim Chancellor and Provost Susan R. Wente, deans, colleagues and family members. Read More

A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. Read More

Four physicians from Vanderbilt University Medical Center (VUMC) have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI). Read More

The National Institutes of Health (NIH) has awarded Vanderbilt’s Department of Pediatrics a K12 training grant to support early career faculty to become physician-scientists, the first time the department has received such an award. Read More

Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS. Read More